Petri
Petri, launched in September 2019, is a Boston-based dynamic startup accelerator focused on helping formation-stage founders realize the next frontier of biology and engineering, co-founded by a team that includes MIT biological engineer Tony Kulesa, serial entrepreneur and investor Brian Baynes, and Pillar Founding Partner Jamie Goldstein. The company equip startups with pre-seed capital (up to $250k), strategic guidance from field experts, and curated access to a huge network of 200+ seasoned mentors, talent from top universities, and 250+ investors and strategic partners.
In February, they launched with their first class of companies, including New Equilibrium Biosciences, founded by Dr. Virginia Burger and Prof. Peter Tompa to create therapeutics targeting undruggable intrinsically disordered proteins in cancer and neurodegenerative diseases. In just a few months, the first class of companies have achieved technical proofs of concept, added key senior team members, won global accolades, and raised millions in follow-on capital.